Bml Capital Management, LLC Top Holdings and 13F Report (2026) About Bml Capital Management, LLCInvestment ActivityBml Capital Management, LLC has $187.62 million in total holdings as of September 30, 2026.Bml Capital Management, LLC owns shares of 20 different stocks, but just 8 companies or ETFs make up 80% of its holdings.Approximately 7.10% of the portfolio was purchased this quarter.About 4.16% of the portfolio was sold this quarter.This quarter, Bml Capital Management, LLC has purchased 18 new stocks and bought additional shares in 4 stocks.Bml Capital Management, LLC sold shares of 4 stocks and completely divested from 1 stock this quarter.Largest Holdings Aclaris Therapeutics $57,623,300Atea Pharmaceuticals $35,186,558ENGENE THERAPEUTICS INC $13,339,816PMV Pharmaceuticals $12,241,100Kraft Heinz $10,792,000 Largest New Holdings this Quarter 81578P106 - Seer $4,876,089 Holding52635N103 - LENZ THERAPEUTICS INC $1,087,158 Holding48576U205 - KARYOPHARM THERAPEUTICS INC $87,644 Holding Largest Purchases this Quarter Seer 2,186,587 shares (about $4.88M)CONNECT BIOPHARMA HLDGS LTD 3,291,113 shares (about $3.62M)PMV Pharmaceuticals 2,000,000 shares (about $3.34M)LENZ THERAPEUTICS INC 283,114 shares (about $1.09M)Kraft Heinz 10,000 shares (about $227.20K) Largest Sales this Quarter Aclaris Therapeutics 1,020,000 shares (about $5.37M)Tesla 225 shares (about $1.04M)Atea Pharmaceuticals 198,672 shares (about $1.04M)Janux Therapeutics 3,835 shares (about $66.27K) Sector Allocation Over TimeMap of 500 Largest Holdings ofBml Capital Management, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorACRSAclaris Therapeutics$57,623,300$5,365,200 ▼-8.5%10,955,00030.7%HealthcareAVIRAtea Pharmaceuticals$35,186,558$1,035,081 ▼-2.9%6,753,65818.8%HealthcareENGENE THERAPEUTICS INC$13,339,8160.0%6,669,9087.1%COMPMVPPMV Pharmaceuticals$12,241,100$3,340,000 ▲37.5%7,330,0006.5%HealthcareKHCKraft Heinz$10,792,000$227,200 ▲2.2%475,0005.8%Consumer StaplesTLYSTilly's$9,954,5000.0%2,150,0005.3%Consumer DiscretionaryKMXCarMax$9,506,4750.0%172,5005.1%Consumer DiscretionaryOUTSET MED INC$7,559,1030.0%2,519,7014.0%COM NEWTGTTarget$5,875,8750.0%37,5003.1%Consumer StaplesSEERSeer$4,876,089$4,876,089 ▲New Holding2,186,5872.6%HealthcareINSTIL BIO INC$4,674,1440.0%645,6002.5%COM NEWCONNECT BIOPHARMA HLDGS LTD$4,250,840$3,620,224 ▲574.1%3,864,4002.3%SHSORMPOramed Pharmaceuticals$4,130,111$84,634 ▲2.1%884,3922.2%HealthcareJANXJanux Therapeutics$2,611,457$66,269 ▼-2.5%151,1261.4%HealthcarePLRXPliant Therapeutics$1,669,8280.0%1,546,1370.9%HealthcareLENZ THERAPEUTICS INC$1,087,158$1,087,158 ▲New Holding283,1140.6%COMIMAGENEBIO INC$919,3430.0%200,7300.5%COMTSLATesla$696,000$1,044,000 ▼-60.0%1500.4%Consumer DiscretionaryWALMART INC$537,6750.0%3350.3%COMKARYOPHARM THERAPEUTICS INC$87,644$87,644 ▲New Holding71,8390.0%COM NEWCORE SCIENTIFIC INC NEW$0$298,000 ▼-100.0%00.0%COMShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
